Integrative Research in Gynecologic Health (R01) | RFA HD 18 017

Opportunity Information: Apply for RFA HD 18 017

The Integrative Research in Gynecologic Health (R01) funding opportunity (RFA-HD-18-017) is a National Institutes of Health (NIH) discretionary grant aimed at advancing research on major gynecologic conditions that affect many patients and are often difficult to diagnose, treat, or fully understand. The central goal is to stimulate integrated and synergistic projects, meaning proposals are expected to connect ideas, methods, or data sources in ways that produce a more complete understanding than separate, single-track studies. The scientific focus areas named in the announcement are uterine fibroids, endometriosis, adenomyosis, and gynecologic pain syndromes, with an emphasis on research approaches that link mechanisms, clinical features, and potentially multiple disciplines to address these complex health problems.

This opportunity uses the NIH R01 mechanism, which typically supports substantial, multi-year research projects led by an experienced investigative team. The funding activity category is listed under Health, Income Security and Social Services (CFDA 93.865). The notice indicates an award ceiling of $499,999, signaling that applications should be scoped to fit within that maximum level of support as defined in the solicitation. The original closing date for applications was March 31, 2017, and the opportunity record shows a creation date of December 16, 2016, placing it within a specific historical funding cycle rather than an open, ongoing program.

A wide range of applicant organizations are eligible, reflecting NIH interest in drawing on many kinds of research environments and community connections. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education); for-profit organizations other than small businesses; small businesses; and other applicant types as allowed by NIH policy and the terms of the announcement. The FOA also explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal government agencies, faith-based or community-based organizations, regional organizations, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions. Taken together, this list signals an intent to encourage participation from institutions serving underrepresented populations and from organizations that can connect research to real-world patient communities.

At the same time, the solicitation is clear about limits on non-U.S. participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible to apply. In addition, foreign components, as defined under the NIH Grants Policy Statement, are not allowed. Practically, this means the applicant organization must be U.S.-based and the funded work must be carried out without foreign components as defined by NIH, reinforcing that the research activities supported under this FOA are intended to remain domestic in scope and performance.

In summary, this FOA supports R01-level, integrated research projects intended to move the field forward on uterine fibroids, endometriosis, adenomyosis, and gynecologic pain syndromes by encouraging collaborations and study designs that combine complementary expertise. It is administered by NIH, capped at a stated maximum award amount, and open to a broad array of U.S. organizations including universities, nonprofits, governments, and certain for-profit entities, while explicitly excluding foreign applicants and foreign components.

• The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Integrative Research in Gynecologic Health (R01)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865.
• This funding opportunity was created on 2016-12-16.
• Applicants must submit their applications by 2017-03-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $499,999.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA HD 18 017

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: